Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round 2022-10-26 14:26
Alwin Capital's New Dual-Currency Fund Closed and Exceeded Fundraising Target 2022-10-25 23:10
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences 2022-10-24 21:00
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities 2022-10-24 08:30
SK bioscience Appoints New Executives towards Global Business Growth 2022-10-21 20:00
Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center & CABIO R&D Center Investment Project 2022-10-20 20:30
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States 2022-10-20 16:20
BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing 2022-10-20 15:27
AASLD 2022 | Ascentage Pharma to Announce Results from First-in-Human Study of IAP Antagonist APG-1387 in an Oral Report at the AASLD Annual Meeting 2022-10-20 07:16
SeekIn Presents New Data Supporting its Pan-cancer Early Detection Test at the Early Detection of Cancer Conference 2022 2022-10-19 20:30
STANDIGM TO ATTEND BIO-EUROPE® 2022 2022-10-19 01:50
CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA 2022-10-18 20:50
Zhiyi Biotech Received Clinical Approval from U.S. FDA for SK10 in Chemotherapy-induced Diarrhea 2022-10-18 20:35
WeTrade Group Announces the Launch of Global Payment System WTPay and Development Plan of Health Business 2022-10-18 17:02
ImmVira announced to launch the construction of Global R&D and Commercialization Base 2022-10-18 16:22
EditForce Realizes RNA-editing Technology of "U-to-C" 2022-10-18 14:00
iNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesis 2022-10-18 11:56
InxMed Releases Data Demonstrating IN10018 Therapeutic Potential in Patients with Metastatic Melanoma at SMR 2022 2022-10-18 08:00
Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia 2022-10-17 20:05
1 69 70 71 72 73 222